Aplastic anemia is a disease.

Written by Li Fang Fang
Hematology
Updated on September 29, 2024
00:00
00:00

Aplastic anemia is a bone marrow failure syndrome, which simply means that the bone marrow's function to produce blood cells is impaired, and it cannot produce the blood cells needed by a normal body. Clinically, it manifests as a series of symptoms caused by the reduction of all blood cells. A reduction in white blood cells can lead to infections in various systems, such as fever, cough, sputum, abdominal pain, diarrhea, frequent urination, urgent urination, and pain during urination. A reduction in red blood cells leads to anemia, which can cause symptoms such as dizziness, headache, fatigue, chest tightness, and palpitations. A decrease in platelets can lead to spontaneous bleeding, such as bleeding in the mouth, gums, and nose, and in severe cases, even cerebral hemorrhage.

Other Voices

doctor image
home-news-image
Written by Zhang Xiao Le
Hematology
44sec home-news-image

Can patients with aplastic anemia drink corn silk water?

Patients with aplastic anemia can drink corn silk tea, but corn silk tea has no therapeutic effect on aplastic anemia. Aplastic anemia is caused by various causes and mechanisms leading to bone marrow failure, mainly characterized by decreased bone marrow hematopoietic function, decreased total blood cells, and the resulting anemia, bleeding, and infection syndrome. The pathogenesis of aplastic anemia is not clear, mainly due to immune abnormalities. The treatment is mainly the use of immunosuppressants such as cyclosporine and hematopoietic agents, primarily androgens. Corn silk tea does not have a therapeutic effect on the mechanisms of this disease.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
59sec home-news-image

What medicine is used to treat aplastic anemia?

Aplastic anemia is divided into acute aplastic anemia and chronic aplastic anemia. Patients with acute aplastic anemia require intensified immunotherapy or allogeneic hematopoietic stem cell transplantation from a sibling match. Intensified immunotherapy involves the simultaneous use of anti-thymocyte globulin (ATG) and cyclosporine. The main treatments for chronic aplastic anemia are immunosuppressive therapy and stimulative hematopoiesis therapy. Immunotherapy primarily involves oral administration of cyclosporine; stimulative hematopoiesis therapy may include oral administration of Chinese patent medicines such as Zao Zeng Xue Pian, and danazol, an anabolic steroid. (Medications should be used under the guidance of a doctor based on the specific circumstances.)

doctor image
home-news-image
Written by Li Fang Fang
Hematology
44sec home-news-image

What medicine is used for aplastic anemia?

Aplastic anemia, whether acute or chronic, primarily uses immunosuppressive agents and hematopoietic stimulants for treatment. Cyclosporine is commonly used clinically among immunosuppressants, while the medicines stimulating bone marrow hematopoiesis mainly include androgens such as danazol and stanozolol. These medications all have associated adverse reactions: immunosuppressants can lead to hypertension, hyperglycemia, impaired liver and kidney function, and gum hypertrophy, while the main adverse reactions of hematopoietic androgens are liver damage. (Please use medications under the guidance of a doctor.)

doctor image
home-news-image
Written by Li Fang Fang
Hematology
45sec home-news-image

What causes aplastic anemia?

Aplastic anemia's exact causes are still not completely clear. Clinically, it is believed that immune dysfunction is a significant factor associated with aplastic anemia. Most cases of aplastic anemia can achieve good therapeutic outcomes through immunosuppressive treatment, which indirectly supports this view. However, some scholars believe that in aplastic anemia, there are patients for whom immunosuppressive treatment is ineffective. This suggests that other factors might exist, such as congenital anomalies in hematopoietic stem and progenitor cells, or abnormalities in the hematopoietic microenvironment, which may also play a role in the development of aplastic anemia.

doctor image
home-news-image
Written by Zhang Xiao Le
Hematology
49sec home-news-image

What tests should be done to diagnose aplastic anemia?

The diagnostic criteria for aplastic anemia include a decrease in all blood cells, generally no enlargement of the liver or spleen, reduced or severe reduction in bone marrow hyperplasia in multiple sites, and exclusion of other diseases causing a decrease in all blood cells. Therefore, the diagnosis of aplastic anemia requires the following tests: complete blood count, reticulocyte count, abdominal ultrasound, bone marrow cytology, bone marrow chromosome analysis, bone marrow biopsy, rheumatoid immune indicators, and peripheral blood T-cell subgroups. Additionally, for patients suspected of having aplastic anemia, further flow cytometry and differentiation from myelodysplastic syndromes are sometimes necessary.